Additionally, in the 2014 national survey, the proportion under treatment for DM was lower among women than among men, 74% and 81% for oral hypoglycemic agent treatment and 6% and 14% for insulin treatment, respectively [10]. The gene discussed is INS; the disease is diabetes mellitus.